# (A Novel Pharmacologic Regime for Elective Percutaneous Coronary Intervention)

> **NCT01031095** · PHASE3 · COMPLETED · sponsor: **Bursa Postgraduate Hospital** · enrollment: 200 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **OTHER:** coronary intervention

## Key facts

- **NCT ID:** NCT01031095
- **Lead sponsor:** Bursa Postgraduate Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2009-12
- **Final completion:** 2010-06
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2014-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01031095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01031095, "(A Novel Pharmacologic Regime for Elective Percutaneous Coronary Intervention)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01031095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*